LDX — Lumos Diagnostics Holdings Share News
0.000.00%
Last trade - 00:00- AU$84.05m
- AU$70.34m
- $13.19m
Brief: Lumos Diagnostics Says Entered Binding Convertible Note Agreements
Brief: Lumos Diagnostics Holdings Records Unaudited Revenue Of A$2.8 Mln For Quarter
Lumos Diagnostics dips after U.S. FDA upholds marketing clearance denial
Brief: Lumos Diagnostics Completed Closure Of Its Sarasota Facility And Relocated Company's Manufacturing Capability To Its Carlsbad Site In California
Brief: Lumos Diagnostics Holdings Says Febridx Has Not Been Granted Clearance For Marketing In U.S
Brief: Lumos Diagnostics Files Appeal To U.S. FDA On Decision Not To Grant Clearance To Market Febridx
Brief: Lumos Diagnostics No Longer Intends To Participate In Establishment Of Diagnostics Manufacturing Facility In Victoria
Brief: Lumos Diagnostics To Close Sarasota Facility
Brief: Lumos Diagnostics Says Advised By FDA That Febridx Did Not Demonstrate Substantial Equivalence To Predicate Device
Lumos Diagnostics posts record drop after U.S. FDA denies marketing clearance
Brief: Lumos Diagnostics Holdings Seeks Trading Halt
Lumos Diagnostics rises on interim nod for COVID test in Canada
Brief: Lumos Diagnostics Says Got Interim Order Authorization From Health Canada For Its Viradx RAT
Brief: Lumos Diagnostics Appoints Doug Ward As CEO
Brief: Lumos Diagnostics Says It Secured Development Services Contract With Aptatek
Brief: Lumos Diagnostics Seeks Trading Halt
Brief: Lumos Diagnostics Posts Unaudited Revenue Of US$3.8 Million For March Quarter
Brief: Lumos Diagnostics Holdings Appoints Sam Lanyon As Interim CEO
Australia Stock Exchange release from LUMOS DIAGNOSTIC : Change in substantial holding